31.01.2021, 2200 Zeichen

Palfinger: Palfinger, a leading international manufacturer of innovative lifting solutions, is currently the target of an ongoing global cyber attack. IT infrastructure is disrupted at the moment (including sending and receiving emails, ERP systems). A large proportion of the group's worldwide locations are affected. It is not possible to estimate the precise extent and duration of the attack or its consequences at this time. "Work is being carried out intensively on a solution", the company stated.
Palfinger: weekly performance: -5.02%

Valneva: Valneva, an Austrian/French specialty vaccine company, and Instituto Butantan, producer of immunobiologic products, today announced the signing of definitive agreements for the development, manufacturing and marketing of Valneva’s single-shot chikungunya vaccine, VLA1553, in Low and Middle Income Countries (LMICs). This finalization follows the signing of a binding term sheet in May 2020.  The collaboration falls within the framework of the USD 23.4 mn funding agreement Valneva signed with the Coalition for Epidemic Preparedness Innovations (CEPI) in July 2019. Under the collaboration, Valneva will transfer its chikungunya vaccine technology to Instituto Butantan, who will develop, manufacture and commercialize the vaccine in LMICs. In addition, Instituto Butantan will provide certain clinical and Phase 4 observational studies that Valneva will use to meet regulatory requirements. The agreement includes small upfront and technology transfer milestones.  Thomas Lingelbach, Chief Executive Officer of Valneva, commented, “The dreadful impact of the COVID-19 pandemic on the world has underlined the importance of vaccines to combat public health crises. Chikungunya outbreaks have impacted over 120 countries and affected millions, yet no vaccine or treatment is currently available to prevent this debilitating disease. We look forward to working with Instituto Butantan to help address this urgent public health need and speed up the development of a chikungunya vaccine in LMICs, which are high outbreak risk areas.”
Valneva: weekly performance: 4.41%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (25/01/2021)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1181: ATX unverändert, AT&S mit der doppelten 600 und MSCI vs. Stoxx, Palfinger nach Auftrag gesucht

Bildnachweis

Aktien auf dem Radar:AT&S, Lenzing, DO&CO, Austriacard Holdings AG, Semperit, EuroTeleSites AG, Erste Group, CPI Europe AG, Verbund, Marinomed Biotech, SBO, voestalpine, Rosgix, EVN, Uniqa, Warimpex, FACC, BTV AG, Zumtobel, BKS Bank Stamm, Amag, Österreichische Post, Telekom Austria, Infineon, IBM, Siemens, Airbus Group, Henkel, Beiersdorf, Symrise, Commerzbank.

---